SEC Form 4 · accession 0001209191-17-057697
TRANSENTERIX INC. · TRXC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph P Slattery
Officer — EVP and CFO
Period of report
Oct 19, 2017
Accepted (ET)
Oct 23, 2017 · 6:56 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876378
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 19, 2017 | M | 150,000 | $1.00 | A | 794,365 | D | |
| Common StockF3 | Oct 19, 2017 | F | 23,391 | $3.73 | D | 770,974 | D | |
| Common Stock | holding | — | — | — | 25,000 | I | By IRA |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Warrants | $1.00 | Oct 19, 2017 | M | 150,000 | D | May 3, 2017 | May 3, 2022 | Common Stock | 150,000 | 0 | D |
Explanation of responses
- F1On October 19, 2017, the reporting person exercised, via a cashless exercise option, Series B warrants to acquire 150,000 shares of common stock of TransEnterix, Inc. (the "Company"), par value $0.001 per share, for an exercise price of $1.00 per share.
- F2In connection with the reporting person's cashless exercise of Series B warrants, the Company withheld 23,391 of the shares to satisfy the exercise price and issued to the reporting person the remaining 126,609 shares.
- F3The volume weighted average price of the common stock calculated as set forth in the Series B warrant was $3.7329.